Great Britain approves subcutaneous Tecentriq weeks ahead of expected US decision
Patients in Great Britain who take IV Tecentriq now have a quicker option.
The country’s regulatory authority has approved a subcutaneous …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
